HODGKIN DISEASE

Clinical trials for HODGKIN DISEASE explained in plain language.

Never miss a new study

Get alerted when new HODGKIN DISEASE trials appear

Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 6 Completed 5 Terminated 1

Early trial tests new weapon against Tough-to-Treat blood cancers

Disease control Terminated

This was an early-stage safety study for an experimental drug called PF-08046045, designed for adults with advanced lymphomas that had stopped responding to other treatments. The main goal was to find a safe dose and understand the drug's side effects. The trial was terminated ea…

Matched conditions: HODGKIN DISEASE

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

HODGKIN DISEASE

Get alerted when new HODGKIN DISEASE trials appear

Early trial tests new weapon against Tough-to-Treat blood cancers